Arrowhead Pharmaceuticals
0 sources
Financials
0000879407-25-000029Arrowhead Pharmaceuticals
Summary
Arrowhead Pharmaceuticals is a public company[1].
Key Facts
- Arrowhead Pharmaceuticals's field of work was RNA interference[2].
- Arrowhead Pharmaceuticals is in the country of United States[3].
- Arrowhead Pharmaceuticals is in the country of US[4].
- Arrowhead Pharmaceuticals's instance of is recorded as public company[5].
- Arrowhead Pharmaceuticals's headquarters location is recorded as Pasadena[6].
- Arrowhead Pharmaceuticals's stock exchange is recorded as Nasdaq[7].
- Arrowhead Pharmaceuticals's industry is recorded as pharmaceutical industry[8].
- 1989 marks the founding of Arrowhead Pharmaceuticals[9].
- 2001-02-13 marks the founding of Arrowhead Pharmaceuticals[10].
- Arrowhead Pharmaceuticals's official website is recorded as https://arrowheadpharma.com/[11].
- Arrowhead Pharmaceuticals's legal form is recorded as Delaware corporation[12].
- Arrowhead Pharmaceuticals's legal form is recorded as XTIQ[13].
Body
Founding
Recorded inception include 1989[9] and 2001-02-13[10].
Operations
Arrowhead Pharmaceuticals's headquarters location is recorded as Pasadena[6].
Industry
Arrowhead Pharmaceuticals's industry is recorded as pharmaceutical industry[8]. Its field of work was RNA interference[2].
Ownership
Arrowhead Pharmaceuticals's stock exchange is recorded as Nasdaq[7].